IRF4 and B-cell non-Hodgkin lymphoma: These results imply that EBNA3C mediated activation of IRF4 and its downstream signalling may deregulate important cellular functions which include proliferation, apoptosis, and cell-cycle which favour the development of B-cell lymphomas.